Bicycle Therapeutics Ltd (BCYC) support and resistance · rev $1.5M
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
This page maps Bicycle Therapeutics Ltd (BCYC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
BCYC currently screens at market cap $554.0M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BCYC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BCYC quote page for the session range and the stock page for the full model.
Not investment advice.